TRANSLATIONAL DEVELOPMENT AC (TDAC) Fundamental Analysis & Valuation

NASDAQ:TDAC • KYG9008W1050

Current stock price

10.61 USD
+0.01 (+0.09%)
Last:

This TDAC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TDAC Profitability Analysis

1.1 Basic Checks

  • TDAC had positive earnings in the past year.
  • In the past year TDAC has reported a negative cash flow from operations.
TDAC Yearly Net Income VS EBIT VS OCF VS FCFTDAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 2M 4M 6M

1.2 Ratios

Industry RankSector Rank
ROA 3.5%
ROE 3.63%
ROIC N/A
ROA(3y)-8092.18%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TDAC Yearly ROA, ROE, ROICTDAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -5K -10K -15K -20K

1.3 Margins

  • TDAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TDAC Yearly Profit, Operating, Gross MarginsTDAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. TDAC Health Analysis

2.1 Basic Checks

  • TDAC has more shares outstanding than it did 1 year ago.
  • TDAC has a worse debt/assets ratio than last year.
TDAC Yearly Shares OutstandingTDAC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M 20M
TDAC Yearly Total Debt VS Total AssetsTDAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 21.10 indicates that TDAC is not in any danger for bankruptcy at the moment.
  • TDAC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.1
ROIC/WACCN/A
WACCN/A
TDAC Yearly LT Debt VS Equity VS FCFTDAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.07 indicates that TDAC may have some problems paying its short term obligations.
  • TDAC has a Quick Ratio of 0.07. This is a bad value and indicates that TDAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
TDAC Yearly Current Assets VS Current LiabilitesTDAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200K 400K 600K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TDAC Growth Analysis

3.1 Past

  • TDAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 7948.65%, which is quite impressive.
EPS 1Y (TTM)7948.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18325%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TDAC Yearly Revenue VS EstimatesTDAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 100M 200M 300M 400M
TDAC Yearly EPS VS EstimatesTDAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. TDAC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 36.59 indicates a quite expensive valuation of TDAC.
  • TDAC's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.53.
Industry RankSector Rank
PE 36.59
Fwd PE N/A
TDAC Price Earnings VS Forward Price EarningsTDAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TDAC Per share dataTDAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TDAC Dividend Analysis

5.1 Amount

  • TDAC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TDAC Fundamentals: All Metrics, Ratios and Statistics

TRANSLATIONAL DEVELOPMENT AC

NASDAQ:TDAC (4/17/2026, 11:12:15 AM)

10.61

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-30
Earnings (Next)05-13
Inst Owners99.33%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap232.47M
Revenue(TTM)N/A
Net Income(TTM)6.36M
Analysts100
Price TargetN/A
Short Float %0%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 36.59
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.29
EY2.73%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS7.99
TBVpS7.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.22156 (-31.94%)
Profitability
Industry RankSector Rank
ROA 3.5%
ROE 3.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-8092.18%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 21.1
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7948.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18325%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-380.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.55%
OCF growth 3YN/A
OCF growth 5YN/A

TRANSLATIONAL DEVELOPMENT AC / TDAC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TRANSLATIONAL DEVELOPMENT AC?

ChartMill assigns a fundamental rating of 1 / 10 to TDAC.


Can you provide the valuation status for TRANSLATIONAL DEVELOPMENT AC?

ChartMill assigns a valuation rating of 0 / 10 to TRANSLATIONAL DEVELOPMENT AC (TDAC). This can be considered as Overvalued.


What is the profitability of TDAC stock?

TRANSLATIONAL DEVELOPMENT AC (TDAC) has a profitability rating of 0 / 10.


Can you provide the financial health for TDAC stock?

The financial health rating of TRANSLATIONAL DEVELOPMENT AC (TDAC) is 1 / 10.